It has been reported that AR, like PgR, can recruit Src and activate MAPK and PI3K/AKT pathways59, key signaling routes also triggered by HER2, suggesting a potential cross-talk among AR, HER2, and PgR that may drive gene dysregulation and promote proliferation, migration, and invasiveness in BC cells. The gene discussed is ERBB2; the disease is breast cancer.